PharVision Advisers’s Cigna CI Stock Holding History

PharVision Advisers’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,258	Closed	-$346K	–	204
2025 Q4	$346K	Buy	1,258 +291	+30%	+$81.6K	0.18%	201
2025 Q3	$279K	Buy	+967	New	+$286K	0.16%	270

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

PharVision Advisers's CI Position: Q1 2026 in Review

PharVision Advisers sold out of Cigna (CI) in Q1 2026, closing a stake of 1,258 shares — an estimated $346K sold.

PharVision Advisers first reported a position in CI in Q3 2025 and held it in 2 quarters. The position peaked at $346K in Q4 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

PharVision Advisers reported no remaining Cigna position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,258 Cigna shares in Q1 2026, an estimated $346K.
PharVision Advisers first reported a position in Cigna in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Cigna position peaked at $346K in Q4 2025.
1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.